Birdwatch Note
2024-02-26 20:20:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Owlet, the company being referred to, was warned by the FDA that they were marketing a medical device without being approved as a medical device. They pulled the product voluntarily to avoid fines. In 2023 they were approved by the FDA. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/owlet-baby-care-inc-616354-10052021 https://owletcare.com/pages/fda-response
Written by 14CDEE17CC125850928C9B5CFA7278408CB4333F43F513379B756E9E924BC7B2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1761878005759217881
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1762211149393567834
- noteId - 1762211149393567834
- participantId -
- noteAuthorParticipantId - 14CDEE17CC125850928C9B5CFA7278408CB4333F43F513379B756E9E924BC7B2 Participant Details
- createdAtMillis - 1708978852976
- tweetId - 1761878005759217881
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Owlet, the company being referred to, was warned by the FDA that they were marketing a medical device without being approved as a medical device. They pulled the product voluntarily to avoid fines. In 2023 they were approved by the FDA. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/owlet-baby-care-inc-616354-10052021 https://owletcare.com/pages/fda-response
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-02-26 20:20:52 UTC (1708978852976) |
2024-02-26 23:19:53 UTC (1708989593292) |
CURRENTLY_RATED_HELPFUL | 2024-02-27 07:06:10 UTC (1709017570610) |
CURRENTLY_RATED_HELPFUL | 2024-02-26 23:19:53 UTC (1708989593292) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-02-26 23:16:35 -0600 | Rating Details | |
2024-02-26 23:09:30 -0600 | Rating Details | |
2024-02-26 20:51:17 -0600 | Rating Details | |
2024-02-26 18:04:00 -0600 | Rating Details | |
2024-02-26 17:13:17 -0600 | Rating Details | |
2024-02-26 16:22:25 -0600 | Rating Details | |
2024-02-26 16:19:10 -0600 | Rating Details | |
2024-02-26 16:19:02 -0600 | Rating Details | |
2024-02-26 16:16:22 -0600 | Rating Details | |
2024-02-26 16:16:05 -0600 | Rating Details | |
2024-02-26 16:15:26 -0600 | Rating Details | |
2024-02-26 16:12:42 -0600 | Rating Details | |
2024-02-26 16:02:26 -0600 | Rating Details | |
2024-02-26 16:01:35 -0600 | Rating Details | |
2024-02-26 16:01:22 -0600 | Rating Details | |
2024-02-26 15:59:27 -0600 | Rating Details | |
2024-02-26 15:57:23 -0600 | Rating Details | |
2024-02-26 15:52:23 -0600 | Rating Details | |
2024-02-26 15:52:16 -0600 | Rating Details | |
2024-02-26 15:52:00 -0600 | Rating Details | |
2024-02-26 15:49:52 -0600 | Rating Details | |
2024-02-26 15:40:47 -0600 | Rating Details | |
2024-02-26 15:39:04 -0600 | Rating Details | |
2024-02-26 15:36:52 -0600 | Rating Details | |
2024-02-26 15:13:30 -0600 | Rating Details | |
2024-02-26 15:05:53 -0600 | Rating Details | |
2024-02-26 15:03:11 -0600 | Rating Details | |
2024-02-26 15:01:06 -0600 | Rating Details | |
2024-02-26 14:33:10 -0600 | Rating Details | |
2024-02-26 14:32:14 -0600 | Rating Details | |
2024-02-26 14:30:35 -0600 | Rating Details | |
2024-02-28 12:46:10 -0600 | Rating Details | |
2024-02-28 05:55:00 -0600 | Rating Details | |
2024-02-27 21:42:29 -0600 | Rating Details | |
2024-02-26 20:57:57 -0600 | Rating Details | |
2024-02-26 19:11:59 -0600 | Rating Details | |
2024-02-26 18:09:26 -0600 | Rating Details | |
2024-02-26 16:24:48 -0600 | Rating Details | |
2024-02-26 16:22:44 -0600 | Rating Details | |
2024-02-26 16:18:02 -0600 | Rating Details | |
2024-02-26 16:11:47 -0600 | Rating Details | |
2024-02-26 16:00:39 -0600 | Rating Details | |
2024-02-26 15:53:36 -0600 | Rating Details | |
2024-02-26 15:50:08 -0600 | Rating Details | |
2024-02-26 15:42:27 -0600 | Rating Details | |
2024-02-26 15:37:57 -0600 | Rating Details | |
2024-02-26 15:37:35 -0600 | Rating Details | |
2024-02-26 15:21:52 -0600 | Rating Details | |
2024-02-26 15:18:33 -0600 | Rating Details | |
2024-02-26 15:18:01 -0600 | Rating Details | |
2024-02-26 15:04:29 -0600 | Rating Details | |
2024-02-26 15:03:31 -0600 | Rating Details | |
2024-02-26 14:57:15 -0600 | Rating Details | |
2024-02-26 14:41:08 -0600 | Rating Details | |
2024-02-26 14:37:21 -0600 | Rating Details | |
2024-02-26 14:34:50 -0600 | Rating Details | |
2024-02-26 14:28:48 -0600 | Rating Details | |
2024-02-26 14:28:33 -0600 | Rating Details | |
2024-02-26 14:28:28 -0600 | Rating Details | |
2024-02-28 04:22:55 -0600 | Rating Details | |
2024-02-28 00:49:18 -0600 | Rating Details | |
2024-02-27 21:43:34 -0600 | Rating Details | |
2024-02-27 21:34:11 -0600 | Rating Details | |
2024-02-26 22:54:48 -0600 | Rating Details | |
2024-02-26 21:40:58 -0600 | Rating Details | |
2024-02-26 20:46:43 -0600 | Rating Details | |
2024-02-26 20:02:40 -0600 | Rating Details | |
2024-02-26 16:47:58 -0600 | Rating Details | |
2024-02-26 16:18:26 -0600 | Rating Details | |
2024-02-26 16:10:17 -0600 | Rating Details | |
2024-02-26 16:08:31 -0600 | Rating Details | |
2024-02-26 16:02:09 -0600 | Rating Details | |
2024-02-26 15:59:37 -0600 | Rating Details | |
2024-02-26 15:46:49 -0600 | Rating Details | |
2024-02-26 15:42:11 -0600 | Rating Details | |
2024-02-26 15:41:57 -0600 | Rating Details | |
2024-02-26 15:39:11 -0600 | Rating Details | |
2024-02-26 15:37:24 -0600 | Rating Details | |
2024-02-26 15:34:04 -0600 | Rating Details | |
2024-02-26 15:30:47 -0600 | Rating Details | |
2024-02-26 15:26:21 -0600 | Rating Details | |
2024-02-26 15:25:10 -0600 | Rating Details | |
2024-02-26 15:23:22 -0600 | Rating Details | |
2024-02-26 15:12:09 -0600 | Rating Details | |
2024-02-26 15:02:40 -0600 | Rating Details | |
2024-02-26 15:01:09 -0600 | Rating Details | |
2024-02-26 14:58:18 -0600 | Rating Details | |
2024-02-26 14:52:40 -0600 | Rating Details | |
2024-02-26 14:45:50 -0600 | Rating Details | |
2024-02-26 14:41:45 -0600 | Rating Details | |
2024-02-26 14:38:39 -0600 | Rating Details | |
2024-02-26 14:24:09 -0600 | Rating Details | |
2024-02-28 04:59:20 -0600 | Rating Details | |
2024-02-27 18:27:22 -0600 | Rating Details | |
2024-02-26 23:37:59 -0600 | Rating Details | |
2024-04-14 11:04:09 -0500 | Rating Details | |
2024-04-14 11:02:03 -0500 | Rating Details |